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The trends reported by Broderick et al. have contin-
ued. During 2006–2014, the incidence of meningococcal 
disease caused by vaccine-covered serogroups among US 
military recipients of MCV-4 fell to 0.146 per 100,000 
person-years, whereas MPVS-4–related incidence did 
not change (M.P. Broderick, pers. comm.). Furthermore, 
through July 2016, the US military has not seen a case 
from a covered serogroup since 2011 among recipients 
of MCV-4. Even with these additional data, however, the 
difference between MCV-4 and MPSV-4 does not achieve 
statistical significance (M.P. Broderick, pers. comm.).
The author is an employee of a company that manufactures both 
conjugate and polysaccharide meningococcal vaccines.
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LETTERS
Correction: Vol. 22, No. 8
The name of author Natalie Witek was misspelled in Baylisascaris procyonis–Associated Meningoencephalitis 
in a Previously Healthy Adult, California, USA (C. Langelier et al.). The article has been corrected online (http://wwwnc.
cdc.gov/eid/article/22/8/15-1939_article).
Corrections: Vol. 22, No. 9
Some descriptions of tickborne transmission of bacteria were unclear in Large-Scale Survey for Tickborne 
Bacteria, Khammouan Province, Laos (A.J. Taylor al.). The article has been corrected online (http://wwwnc.cdc.gov/eid/
article/22/9/15-1969_article).
A second affiliation for author Martie L. van der Walt was omitted in Treatment Outcomes for Patients with 
Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa (C.L. Kvasnovsky 
et al.). The article has been corrected online (http://wwwnc.cdc.gov/eid/article/22/9/16-0084_article).
Visit our website to listen: http://www2c.cdc.gov/podcasts/player.asp?f=8642667
EID Podcast: Nipah Virus Transmission from  
Bats to Humans Associated with Drinking  
Traditional Liquor Made from Date Palm Sap,  
Bangladesh, 2011–2014
Nipah virus (NiV) is a paramyxovirus, and Pteropus spp. bats are the natural reservoir. 
From December 2010 through March 2014, hospital-based encephalitis surveillance 
in Bangladesh identified 18 clusters of NiV infection. A team of 
epidemiologists and anthropologists investigated and found that 
among the 14 case-patients, 8 drank fermented date palm 
sap (tari) regularly before their illness, and 6 provided care 
to a person infected with NiV. The process of preparing date 
palm trees for tari production was similar to the process of 
collecting date palm sap for fresh consumption. Bat excreta 
was reportedly found inside pots used to make tari. These 
findings suggest that drinking tari is a potential pathway of 
NiV transmission.
